U.S. Downstream Processing Market Size, Share & Trends Analysis Report By Product (Chromatography Systems, Filters), By Technique (Cell Disruption, Formulation), By Application (Antibiotic Production), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Information Procurement
                   1.2. Information Or Data Analysis
                   1.3. Market Scope & Segment Definition
                   1.4. Market Model
                       1.4.1. Market Study, By Company Market Share
Chapter 2. Executive Summary
                   2.1. Market Snapshot
                   2.2. Segment Snapshot
                   2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent Market Outlook
                       3.1.2. Related/Ancillary Market Outlook
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                           3.2.1.1. Commercial Success of Biopharmaceuticals Boosts Demand For Innovation In Bioprocessing
                           3.2.1.2. Rising Adoption of Single-Use Technology In Bioprocessing
                           3.2.1.3. Environmental Advantage
                           3.2.1.4. Operating And Construction Cost Advantage
                           3.2.1.5. Flexibility Advantage
                           3.2.1.6. Time Advantage
                           3.2.1.7. Expansion Of Bioprocessing Capacity
                       3.2.2. Market Restraint Analysis
                           3.2.2.1. High Cost
                           3.2.2.2. Dearth Of Skilled Professionals
                   3.3. Industry Analysis Tools
                       3.3.1. Porter’s Five Forces Analysis
                       3.3.2. PESTEL Analysis
                       3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
                   4.1. U.S. Downstream Processing Market: Segment Dashboard
                   4.2. U.S. Downstream Processing Market: Product Movement Analysis
                   4.3. Chromatography Systems
                       4.3.1. Chromatography Systems Market, 2018 - 2030 (USD Billion)
                   4.4. Filters
                       4.4.1. Filters Market, 2018 - 2030 (USD Billion)
                   4.5. Evaporators
                       4.5.1. Evaporators Market, 2018 - 2030 (USD Billion)
                   4.6. Centrifuges
                       4.6.1. Centrifuges Market, 2018 - 2030 (USD Billion)
                   4.7. Dryers
                       4.7.1. Dryers Market, 2018 - 2030 (USD Billion)
                   4.8. Others
                       4.8.1. Other Products Market, 2018 - 2030 (USD Billion)
Chapter 5. Technique Business Analysis
                   5.1. U.S. Downstream Processing Market: Segment Dashboard
                   5.2. U.S. Downstream Processing Market: Technique Movement Analysis
                   5.3. Cell Disruption
                       5.3.1. Cell Disruption Market, 2018 - 2030 (USD Billion)
                   5.4. Solid-liquid Separation
                       5.4.1. Solid-liquid Separation Market, 2018 - 2030 (USD Billion)
                       5.4.2. Filtration
                           5.4.2.1. Filtration Market, 2018 - 2030 (USD Billion)
                       5.4.3. Centrifugation
                           5.4.3.1. Centrifugation Market, 2018 - 2030 (USD Billion)
                   5.5. Concentration
                       5.5.1. Concentration Market, 2018 - 2030 (USD Billion)
                       5.5.2. Evaporation
                           5.5.2.1. Evaporation Market, 2018 - 2030 (USD Billion)
                       5.5.3. Membrane Filtration
                           5.5.3.1. Membrane Filtration Market, 2018 - 2030 (USD Billion)
                   5.6. Purification By Chromatography
                       5.6.1. Purification By Chromatography Market, 2018 - 2030 (USD Billion)
                   5.7. Formulation
                       5.7.1. Formulation Market, 2018 - 2030 (USD Billion)
Chapter 6. Application Business Analysis
                   6.1. U.S. Downstream Processing Market: Segment Dashboard
                   6.2. U.S. Downstream Processing Market: Application Movement Analysis
                   6.3. Antibiotic Production
                       6.3.1. Antibiotic Production Market, 2018 - 2030 (USD Billion)
                   6.4. Hormone Production
                       6.4.1. Hormone Production Market, 2018 - 2030 (USD Billion)
                   6.5. Antibodies Production
                       6.5.1. Antibodies Production Market, 2018 - 2030 (USD Billion)
                   6.6. Enzyme Production
                       6.6.1. Enzyme Production Market, 2018 - 2030 (USD Billion)
                   6.7. Vaccine Production
                       6.7.1. Vaccine Production Market, 2018 - 2030 (USD Billion)
Chapter 7. Competitive Landscape
                   7.1. Company Categorization
                   7.2. Strategy Mapping
                   7.3. Company Market Share Analysis, 2022
                   7.4. Company Profiles/Listing
                       7.4.1. Merck KGaA
                           7.4.1.1. Overview
                           7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.1.3. Product Benchmarking
                           7.4.1.4. Strategic Initiatives
                       7.4.2. Sartorius Stedim Biotech S.A
                           7.4.2.1. Overview
                           7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.2.3. Product Benchmarking
                           7.4.2.4. Strategic Initiatives
                       7.4.3. GE Healthcare
                           7.4.3.1. Overview
                           7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.3.3. Product Benchmarking
                           7.4.3.4. Strategic Initiatives
                       7.4.4. Thermo Fisher Scientific, Inc.
                           7.4.4.1. Overview
                           7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.4.3. Product Benchmarking
                           7.4.4.4. Strategic Initiatives
                       7.4.5. Danaher Corporation
                           7.4.5.1. Overview
                           7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.5.3. Product Benchmarking
                           7.4.5.4. Strategic Initiatives
                       7.4.6. Repligen
                           7.4.6.1. Overview
                           7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.6.3. Product Benchmarking
                           7.4.6.4. Strategic Initiatives
                       7.4.7. 3M Company
                           7.4.7.1. Overview
                           7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.7.3. Product Benchmarking
                           7.4.7.4. Strategic Initiatives
                       7.4.8. Boehringer Ingelheim International GmbH
                           7.4.8.1. Overview
                           7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.8.3. Product Benchmarking
                           7.4.8.4. Strategic Initiatives
                       7.4.9. Corning Corporation
                           7.4.9.1. Overview
                           7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.9.3. Product Benchmarking
                           7.4.9.4. Strategic Initiatives
                       7.4.10. Lonza Group Ltd
                           7.4.10.1. Overview
                           7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.10.3. Product Benchmarking
                           7.4.10.4. Strategic Initiatives
                       7.4.11. Dover Corporation
                           7.4.11.1. Overview
                           7.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.11.3. Product Benchmarking
                           7.4.11.4. Strategic Initiatives
                       7.4.12. Ashai Kasei
                           7.4.12.1. Overview
                           7.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.12.3. Product Benchmarking
                           7.4.12.4. Strategic Initiatives
                       7.4.13. Ferner PLC
                           7.4.13.1. Overview
                           7.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.13.3. Product Benchmarking
                           7.4.13.4. Strategic Initiatives
                       7.4.14. Eppendorf A
                           7.4.14.1. Overview
                           7.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.14.3. Product Benchmarking
                           7.4.14.4. Strategic Initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. downstream processing market, by product, 2018 - 2030 (USD Billion)
Table 3 U.S. downstream processing market, by technique, 2018 - 2030 (USD Billion)
Table 4 U.S. downstream processing market, by application, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Downstream processing market segmentation
Fig. 8 Market snapshot, 2023
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter’s Five Forces analysis
Fig. 14 U.S. downstream processing market: Product outlook key takeaways
Fig. 15 U.S. downstream processing market: Product movement analysis
Fig. 16 U.S. downstream processing market for chromatography systems, 2018 - 2030 (USD Billion)
Fig. 17 U.S. downstream processing market for filters, 2018 - 2030 (USD Billion)
Fig. 18 U.S. downstream processing market for evaporators, 2018 - 2030 (USD Billion)
Fig. 19 U.S. downstream processing market for centrifuges, 2018 - 2030 (USD Billion)
Fig. 20 U.S. downstream processing market for dryers, 2018 - 2030 (USD Billion)
Fig. 21 U.S. downstream processing market for other products, 2018 - 2030 (USD Billion)
Fig. 22 U.S. downstream processing market: Technique outlook key takeaways
Fig. 23 U.S. downstream processing market: Technique movement analysis
Fig. 24 U.S. downstream processing market for cell disruption, 2018 - 2030 (USD Billion)
Fig. 25 U.S. downstream processing market for solid-liquid separation, 2018 - 2030 (USD Billion)
Fig. 26 U.S. downstream processing market for filtration, 2018 - 2030 (USD Billion)
Fig. 27 U.S. downstream processing market for centrifugation, 2018 - 2030 (USD Billion)
Fig. 28 U.S. downstream processing market for concentration, 2018 - 2030 (USD Billion)
Fig. 29 U.S. downstream processing market for evaporation, 2018 - 2030 (USD Billion)
Fig. 30 U.S. downstream processing market for membrane filtration, 2018 - 2030 (USD Billion)
Fig. 31 U.S. downstream processing market for purification by chromatography, 2018 - 2030 (USD Billion)
Fig. 32 U.S. downstream processing market for formulation, 2018 - 2030 (USD Billion)
Fig. 33 U.S. downstream processing market: Application outlook key takeaways
Fig. 34 U.S. downstream processing market: Application movement analysis
Fig. 35 U.S. downstream processing market for antibiotic production, 2018 - 2030 (USD Billion)
Fig. 36 U.S. downstream processing market for hormone production, 2018 - 2030 (USD Billion)
Fig. 37 U.S. downstream processing market for antibodies production, 2018 - 2030 (USD Billion)
Fig. 38 U.S. downstream processing market for enzyme production, 2018 - 2030 (USD Billion)
Fig. 39 U.S. downstream processing market for vaccine production, 2018 - 2030 (USD Billion)